| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate |
1988-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf450c2ccabd9829091dce5b5fab8486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbf9d97d4d9fcc4c003ec0bb7c9488d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f89d064eda26a8246e146203f6445d9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963e4d2add708e0bd7d21e92837d7181 |
| publicationDate |
1988-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0292923-A2 |
| titleOfInvention |
Piperidine compounds and pharmaceutical uses thereof |
| abstract |
Piperidine compounds of the formula:n or isomers thereof as well as pharmaceutically acceptable salt and/or hydrate forms thereof, and piperidine compounds of the formula:n or isomers thereof as well as salt and/or hydrate forms thereof. n In the above formulae, A represents a methylene group, an oxygen atom or a sulfur atom; B represents an oxygen atom or a sulfur atom; R¹ and R² independently represent a hydrogen atom, a lower alkyl group or an aralkyl group; R³ represents a hydrogen atom or an amino protecting group; Z represents an amino group or a protected amino group, a hydroxy group, or a reactive atom or group; m represents 1 or 2; and n represents the integer of 0 to 3. n Piperidine compounds (I) possess an inhibitory activity against angiotensin-converting enzyme, and exhibit a long lasting hypotensive activity and are useful as anti-hypertensive agents. Piperidine compounds (II) are useful as intermediates for said piperidine compounds (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0646115-B1 |
| priorityDate |
1987-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |